Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOW CYCLO: Low vs Usual Dose Ciclosporine in Cardiac Transplant
NCT00159159Phase 4Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciclosporin in cardiac transplant rejection (HTR) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Evolution of serum creatinine level at 12 months. Status: unknown.
02
Drugs
ciclosporin
03
Conditions
cardiac transplant rejection (HTR)
Beyond the preview
Go deeper on NCT00159159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159159.